MORELLO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.991
EU - Europa 1.996
AS - Asia 1.874
SA - Sud America 420
AF - Africa 65
OC - Oceania 9
Totale 7.355
Nazione #
US - Stati Uniti d'America 2.900
SG - Singapore 763
IT - Italia 603
CN - Cina 484
BR - Brasile 359
PL - Polonia 312
DE - Germania 256
HK - Hong Kong 219
UA - Ucraina 160
FI - Finlandia 147
VN - Vietnam 123
GB - Regno Unito 108
RU - Federazione Russa 97
TR - Turchia 72
FR - Francia 66
IN - India 59
CA - Canada 50
IE - Irlanda 47
SE - Svezia 43
NL - Olanda 34
MX - Messico 31
CZ - Repubblica Ceca 30
BD - Bangladesh 29
BE - Belgio 20
JP - Giappone 20
ZA - Sudafrica 20
ES - Italia 18
AR - Argentina 17
IQ - Iraq 17
ID - Indonesia 15
TH - Thailandia 13
AT - Austria 11
EC - Ecuador 11
CO - Colombia 10
PT - Portogallo 10
EG - Egitto 9
ET - Etiopia 9
PK - Pakistan 9
AU - Australia 8
MA - Marocco 7
MY - Malesia 7
VE - Venezuela 7
AZ - Azerbaigian 6
GR - Grecia 6
PY - Paraguay 6
DK - Danimarca 5
GH - Ghana 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
IR - Iran 4
KE - Kenya 4
LK - Sri Lanka 4
LT - Lituania 4
NO - Norvegia 4
HU - Ungheria 3
IL - Israele 3
PE - Perù 3
SA - Arabia Saudita 3
TW - Taiwan 3
UG - Uganda 3
UY - Uruguay 3
UZ - Uzbekistan 3
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
EE - Estonia 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TT - Trinidad e Tobago 1
Totale 7.355
Città #
Singapore 336
Ashburn 321
Warsaw 302
Fairfield 238
Hong Kong 217
New York 161
Woodbridge 149
Beijing 144
Chandler 139
Brescia 131
Jacksonville 125
Seattle 117
Munich 115
Ann Arbor 109
Houston 104
Los Angeles 104
Wilmington 93
Helsinki 86
Princeton 77
Dallas 70
Cambridge 66
Des Moines 66
Milan 63
Istanbul 49
Dublin 47
Boardman 45
Turku 43
Shanghai 41
Rome 37
São Paulo 37
Ho Chi Minh City 36
San Francisco 35
Chicago 34
Moscow 33
The Dalles 30
Buffalo 29
Redondo Beach 29
Hanoi 28
Nanjing 24
Brno 22
London 21
Santa Clara 21
Brooklyn 20
Brussels 19
Nuremberg 19
Tokyo 19
Toronto 18
Naples 17
Denver 16
Frankfurt am Main 16
Stockholm 16
Charlotte 15
Poplar 15
Changsha 14
Johannesburg 14
Montreal 14
Phoenix 14
Tianjin 14
Florence 13
Pune 13
Boston 12
Mexico City 12
Verona 12
Chennai 11
Jinan 11
San Diego 11
Barlassina 10
Orem 10
Wroclaw 10
Amsterdam 9
Pavia 9
Addis Ababa 8
Atlanta 8
Lappeenranta 8
Manchester 8
Mumbai 8
Romola 8
Shenyang 8
Belo Horizonte 7
Bosio 7
Gorlago 7
Guangzhou 7
Lauterbourg 7
Olomouc 7
Rio de Janeiro 7
Alessandria 6
Baghdad 6
Bangkok 6
Bergamo 6
Brasília 6
Dong Ket 6
Düsseldorf 6
Falkenstein 6
Nanchang 6
Newark 6
Porto 6
Roubaix 6
Turin 6
Accra 5
Ancona 5
Totale 4.570
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 272
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 269
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 184
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 174
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 156
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 154
Malnutrizione, valutazione nutrizionale e aspetti dietetici 148
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 145
OUR FOOD, OUR HEALTH: NOURISHING BIODIVERSITY TO HEAL OURSELVES AND THE PLANET Slow Food’s Position Paper on Food and Health 144
Advances in CMV Management: A Single Center Real-Life Experience 138
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 137
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 135
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 134
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 129
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 127
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 127
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 122
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 117
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 113
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. 111
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 108
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS 107
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 107
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. 106
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 105
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 105
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 104
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 104
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 103
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 102
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 100
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 98
Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS) 96
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 93
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 93
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 92
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 92
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 91
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 90
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin's lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability 89
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 88
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 87
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 87
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 85
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 83
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 83
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 82
RIC Allogeneic Transplantation Improves the Overall and Progression-Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLA-Typing and Donor Availability. 82
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 82
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 81
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 80
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 77
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 76
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 75
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 74
Nutritional strategies to improve VRE control 74
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 71
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 71
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults 68
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 68
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 66
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 65
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 63
Superiority of RIC allogeneic transplantation over conventional treatment for HL patients relapsing after autologous transplantation: a GITMO retrospective study based on time of HLA-typing and donor availability. 61
P. aeruginosa bloodstream infections among hematological patients: an old or new question? 58
Moving the Care Process in the in-Home Context: The Therapeutic Prescription 58
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 57
Aspetti Clinici della cGVHD polmonare 57
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 57
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study 54
I diritti del malato 52
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 49
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group 36
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 34
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 31
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 31
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 28
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 25
Totale 7.477
Categoria #
all - tutte 37.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 83 36 68 60 99 55 35
2021/2022378 28 31 7 29 11 33 16 32 18 64 28 81
2022/2023451 54 12 18 40 44 99 3 54 53 13 30 31
2023/2024675 40 16 55 38 34 156 28 26 118 9 17 138
2024/20252.054 41 54 24 188 178 165 135 132 323 181 350 283
2025/20262.183 357 419 289 577 483 58 0 0 0 0 0 0
Totale 7.477